Halobetasol Propionate

CAS 66852-54-8 7 current records 2 historicalSmall Molecule

Who holds supplier records for Halobetasol Propionate? 7 organisations hold a current record for Halobetasol Propionate: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: Italy (2), Israel (2), Portugal (1), India (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Halobetasol Propionate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/halobetasol-propionate

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Halobetasol Propionate expires 19 Jun 2033. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Halobetasol Propionate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Halobetasol Propionate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Halobetasol Propionate are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 16944 · filed Nov 2003
  • United States · Inactive DMF 16329 · filed Dec 2002

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (10 listed products contain Halobetasol Propionate). The latest listed patent expires 19 Jun 2033. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Halobetasol Propionate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200908).

Chemical identity

IUPAC name
[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
Canonical SMILES
CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)CCl
InChIKey
BDSYKGHYMJNPAB-LICBFIPMSA-N
Synonyms
21-chloro diflorasone, BMY-30056, Bryhali, CGP-14,458, CGP-14458, Halobetasol, Halobetasol propionate, Halobetasol propionate component of duobrii, Halobetasol propionate component of idp-118, IDP-122, Jemdel, Lexette

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Halobetasol Propionate?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Halobetasol Propionate: Hovione FarmaCiencia SA (Portugal), STERLING SPA (Italy), SYMBIOTEC PHARMALAB PRIVATE LTD (India), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (Malaysia), Taro Pharmaceutical Industries Ltd. (Israel), TRIFARMA SPA (Italy) and WAVELENGTH ENTERPRISES LTD (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Halobetasol Propionate Drug Master Files are active?

Hovione FarmaCiencia SA (DMF 16953), STERLING SPA (DMF 16861), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 19402), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (DMF 30906), Taro Pharmaceutical Industries Ltd. (DMF 17529), TRIFARMA SPA (DMF 18566) and WAVELENGTH ENTERPRISES LTD (DMF 16856). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Halobetasol Propionate records mean?

2 organisations have only inactive Type II DMFs for Halobetasol Propionate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does the FDA Orange Book list patents for products containing Halobetasol Propionate?

Yes. The latest patent listed for an approved US product containing Halobetasol Propionate expires 19 Jun 2033, across 10 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Halobetasol Propionate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Halobetasol Propionate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.